Why Eli Lilly shares should be up on its latest news, plus Nvidia keeps rolling

Original Article:

Source: Link

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We're no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Nvidia vs. the rest: The markets are off to a mixed start to this holiday-shortened week. Nvidia continues to chug higher, extending its post-earnings run to about 20% and bringing its market capitalization to roughly $2.8 trillion. The Nasdaq gained 0.4%, breaking above 17,000 for the first time ever. But outside of the chipmaker and some of the direct beneficiaries of the AI infrastructure build-out, the broader market is having a tougher day as it deals with rising Treasury yields. "There's not enough money to take up Nvidia this much and the rest of the market," Jim Cramer said. "The money is coming out from companies you'd usually buy for being recession-proof." Indeed, two of the worst performing sectors as of midday Tuesday were defensive: healthcare and consumer staples. Salesforce squeezed : Salesforce has been getting hit on both sides of the M & A coin recently. The stock sold off in April on concerns that management would break its margin and expense discipline by re-engaging in large-scale acquisitions through buying Informatica . At the same time, the stock is pulling back Tuesday on speculation that Alphabet is interested in buying HubSpot , a marketing software company that competes with Salesforce. CNBC's David Faber confirmed those talks were true Tuesday on "Squawk on the Street." Salesforce reports Wednesday after the closing bell and the enterprise software company will have to show it has enough growth to ease concerns that it needs to buy something. No love for Lilly news: Eli Lilly has been on a tear over the past couple of years and made a new all-time high last Thursday. But we're a little surprised by how the stock hasn't reacted to its latest GLP-1 capacity expansion announcement. The company said Friday it has more than doubled its investment in an Indiana manufacturing site with a new $5.3 billion commitment. While it will take several years before this site makes medicine, investing to expand its manufacturing footprint is smart because it will ease future capacity constraints. Management having greater visibility into its production expansion was a key reason why it was able to raise its full-year sales outlook by $2 billion in the first quarter. "When you have to build to meet demand, you have a pretty high quality problem," Cramer said. Up next: The Mediterranean fast casual chain Cava reports after the closing bell. Abercrombie & Fitch , Chewy , Dick's Sporting Goods , and Advance Auto Parts reports Wednesday morning. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED. Jensen Huang, co-founder and CEO of Nvidia, during the Nvidia GPU Technology Conference in San Jose, California, on March 19, 2024. David Paul Morris | Bloomberg | Getty Images